L. J. Haňka
- Molecular Biology
- Organic Chemistry top 10%
- Pharmacology top 10%
- Oncology
- Toxicology top 5%
- Co-authors
- David G. MartinA DietzSandra L. KuentzelG L NeilCarolyn BilesL. M. ReinekeWilliam C. KruegerS. A. MIZSAK
- Topics
- Microbial Natural Products and Biosynthesis (9 papers)Fungal Biology and Applications (7 papers)Cancer therapeutics and mechanisms (6 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
L. J. Haňka
30 papers receiving 603 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 453
- Organic Chemistry 243
- Pharmacology 154
- Oncology 84
- Toxicology 53
Countries citing papers authored by L. J. Haňka
This map shows the geographic impact of L. J. Haňka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. J. Haňka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. J. Haňka more than expected).
Fields of papers citing papers by L. J. Haňka
This network shows the impact of papers produced by L. J. Haňka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. J. Haňka. The network helps show where L. J. Haňka may publish in the future.
Co-authorship network of co-authors of L. J. Haňka
This figure shows the co-authorship network connecting the top 25 collaborators of L. J. Haňka. A scholar is included among the top collaborators of L. J. Haňka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. J. Haňka. L. J. Haňka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 13 | |
| 7 | 229 | |
| 8 | 4 | |
| 9 | Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice. | 20 |
| 10 | A new antitumor agent, (alphas, 4s, 5r)-alpha-amino-3-chloro-4-hydroxy-4,5-dihydro-5-isoxazoleacetic acid (NSC-176324): preliminary evaluation against L 1210 mouse leukemia in vivo. | 3 |
| 11 | A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. | 21 |
| 12 | 36 | |
| 13 | 6 | |
| 14 | 10 | |
| 15 | 1 | |
| 16 | 7 | |
| 17 | 22 | |
| 18 | 3 | |
| 19 | 3 | |
| 20 | 32 |
About L. J. Haňka
L. J. Haňka is a scholar working on Microbiology, Applied Microbiology and Biotechnology and Pharmacology, having authored 31 papers that have together received 675 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (9 papers), Fungal Biology and Applications (7 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Toxicology (53 citations), Pharmacology (154 citations) and Organic Chemistry (243 citations). L. J. Haňka has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include David G. Martin, A Dietz, Sandra L. Kuentzel, G L Neil, Carolyn Biles, L. M. Reineke, William C. Krueger, S. A. MIZSAK, J. Patrick McGovren and R. B. Kelly. Their work appears in journals such as Science, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.